Roger E. G. Schutgens

Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B

Wolfgang Miesbach, Karina Meijer, Michiel Coppens et al. · Blood · 2017 · 295 citations · Full text

Clinical severity of haemophilia A: does the classification of the 1950s still stand?

I. E. M. DEN UIJL, E. P. Mauser Bunschoten, G. Roosendaal et al. · Haemophilia · 2011 · 236 citations

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia

Martin Teraa, Ralf W. Sprengers, Roger E. G. Schutgens et al. · Circulation · 2015 · 178 citations · Full text

Combination of a Normal D-Dimer Concentration and a Non-High Pretest Clinical Probability Score Is a Safe Strategy to Exclude Deep Venous Thrombosis

Roger E. G. Schutgens, Pernilla Y Ackermark, Fred J.L.M. Haas et al. · Circulation · 2003 · 175 citations

Out of hospital treatment of acute pulmonary embolism in patients with a low NT‐proBNP level

Mariëtte J Agterof, Roger E. G. Schutgens, Repke J. Snijder et al. · Journal of Thrombosis and Haemostasis · 2010 · 135 citations · Full text

Pulmonary Embolism, Critical Care Medicine, Thrombosis +8